Stock listing

NASDAQ:MACK Merrimack Pharmaceuticals Inc Stock

Follow Merrimack Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:MACK

$15.13 USD

Close on May 17, 2024 · No longer trades

Sep 6, 2017 to last close +28.4% · weekly closes, Sep 6, 2017 – May 17, 2024
Lowest – highest close
$1.63 – $15.13 USDSince Sep 6, 2017 · lowest Mar 20, 2020 · highest May 15, 2024

Delisted NASDAQ:MACK no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MACK
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Merrimack Pharmaceuticals Inc on 6ix

Decks
2 decks · latest Jan 9, 2017

Decks

DeckKindSlidesDate
Merger or Acquisition (January 2017)Merger or acquisition26 slidesJan 9, 2017
Investor Presentation (September 2013)Investor deck21 slidesSep 9, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Green
Other companies: Cogent Biosciences, Inc. (Chief Financial Officer · Since at least Jan 31, 2019); Dicerna Pharmaceuticals Inc (Chief Financial Officer · Jan 1, 2016 – Apr 20, 2020 · Past); Verastem, Inc. (Chief Financial Officer · May 10, 2013 – Jan 1, 2016 · Past); GTC Biotherapeutics Inc (Senior VP and CFO · Mar 10, 2006 – Nov 2, 2009 · Past)
Principal Accounting Officer · Jun 14, 2017 – Jun 14, 2017 · Past
Sarah E. Nash
Other companies: Bath & Body Works, Inc. (Board Chair · Since at least May 16, 2019); Blackbaud, Inc. (Director · Jul 27, 2010 – Nov 19, 2024 · Past); Knoll Inc (Director · Sep 27, 2006 – Jul 19, 2021 · Past); Pathmark Stores Inc (Director · Jun 8, 2006 – Dec 3, 2007 · Past)
Director · Jan 31, 2012 – May 13, 2014 · Past
Jean Franchi
Other companies: Disc Medicine, Inc. (Chief Financial Officer · Since at least Feb 7, 2024); Biodesix, Inc. (Director · Since at least Oct 27, 2020); Replimune Group, Inc. (Chief Financial Officer · Dec 9, 2019 – May 16, 2023 · Past)
Chief Financial Officer · Feb 15, 2018 – Dec 11, 2018 · Past
John M. Dineen
Other companies: Lam Research Corporation (President · Since at least Aug 24, 2023); Cognizant Technology Solutions Corporation (Director · Since at least Apr 1, 2017); Syneos Health Inc (Director · Dec 10, 2018 – Sep 28, 2023 · Past)
Director · Jun 15, 2015 – Jun 13, 2018 · Past
Michael E Porter
Other companies: Scotts Miracle-Gro Company (The) (Director · Jan 17, 2013 – Jan 29, 2015 · Past); Thermo Fisher Scientific Inc (Director · May 24, 2006 – Mar 8, 2012 · Past); PTC Inc. (Director · Feb 6, 2006 – Mar 4, 2015 · Past)
Director · Jan 31, 2012 – Sep 13, 2017 · Past
Noah Levy
Other companies: Gesher Acquisition Corp. II (Independent Director · Since at least Nov 5, 2026); Inflection Point Acquisition Corp. III (Director · Apr 24, 2025 – Apr 24, 2025 · Past); Gesher I Acquisition Corp (Director · Oct 12, 2021 – Oct 12, 2021 · Past)
Director · Dec 30, 2022 – Jan 12, 2023 · Past
George Demetri
Other companies: Translate Bio Inc (Director · Jul 12, 2019 – Sep 14, 2021 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 21, 2022 · Past)
Director · Nov 29, 2017 – Jun 13, 2018 · Past
James H Quigley
Other companies: Hess Corporation (Director · Since at least Mar 1, 2013); Wells Fargo & Company (Director · Oct 22, 2013 – Apr 23, 2019 · Past)
Director · Jul 12, 2012 – Jun 13, 2018 · Past
Richard Peters
Other companies: Kineta Inc. (Director · Since at least Dec 22, 2020); Aprea Therapeutics, Inc. (Director · Since at least Jun 26, 2020)
President and CEO, Director · May 8, 2019 – May 8, 2019 · Past
Yasir Al-Wakeel
Other companies: MaxCyte, Inc. (Non-Executive Director · Since at least Jul 29, 2021); Kronos Bio Inc (Chief Financial Officer · Oct 8, 2020 – Jul 6, 2023 · Past)
CFO and Head of Corp Dev · Aug 11, 2015 – Feb 8, 2016 · Past
All 34 people
PersonSeat
Anthony J Sinskey
Other companies: Metabolix Inc (Director · Nov 9, 2006 – Sep 10, 2015 · Past)
Director · Jan 31, 2012 – Dec 18, 2014 · Past
Jeffrey A Munsie
Other companies: Concert Pharmaceuticals Inc (Chief Legal Officer · Sep 23, 2019 – Mar 6, 2023 · Past)
General Counsel · Mar 31, 2017 – Dec 11, 2018 · Past
Robert C Gay
Other companies: Angel Studios, Inc. (Director · Since at least Sep 10, 2025)
Director · Jan 31, 2012 – Apr 3, 2012 · Past
Russell T Ray
Other companies: Forum Markets, Incorporated (Director · Jul 9, 2021 – Sep 4, 2023 · Past)
Director · Jan 1, 2015 – Dec 31, 2021 · Past
Sergio L Santillana
Other companies: ImageneBio, Inc. (Chief Medical Officer · Mar 25, 2021 – Jan 3, 2023 · Past)
Chief Medical Officer · Jun 12, 2017 – Dec 11, 2018 · Past
Vivian S. Lee
Other companies: Zions Bancorporation N.A. (Director · Since at least Mar 19, 2015)
Director · Nov 12, 2014 – Sep 13, 2017 · Past
Walter M Phd Lovenberg
Other companies: Osi Pharmaceuticals Inc (Director · Mar 10, 2006 – Mar 1, 2007 · Past)
Director · Jan 31, 2012 – Apr 25, 2012 · Past
William A Sullivan
Other companies: Zivo Bioscience, Inc. (Chief Financial Officer · Since at least Dec 19, 2025)
Principal Accounting Officer · Jan 31, 2012 – Feb 8, 2016 · Past
Ana RadeljevicDirector · Jun 6, 2022 – Jun 6, 2023 · Past
Birgit M SchoeberlHead of Discovery · Jan 30, 2015 – Jul 25, 2016 · Past
Clet M NiyikizaEVP of Development · Jan 31, 2012 – Mar 12, 2013 · Past
Daryl C DrummondHead of Research · Mar 31, 2017 – Dec 11, 2018 · Past
Edward J StewartHead of Commercial · Jul 15, 2015 – Jul 26, 2016 · Past
Eric AndersenDirector · Dec 29, 2022 – Dec 26, 2023 · Past
Fazal R KhanSVP of Manufacturing · Jan 31, 2012 – Feb 11, 2014 · Past
Gary L CrockerSee Remarks, Director · Jun 13, 2018 – Aug 10, 2023 · Past
Gordon J FehrDirector · Jan 31, 2012 – May 13, 2015 · Past
James van B DresserDirector · Jan 31, 2012 – Jun 2, 2014 · Past
John MendelsohnDirector · Jun 13, 2012 – Sep 13, 2017 · Past
Peter N LaivinsHead of Development · May 14, 2014 – Feb 8, 2016 · Past
Robert J MulroyPresident and CEO, Director · Jan 31, 2012 – Feb 8, 2016 · Past
Thomas E Needham JrChief Business Officer · Jul 24, 2017 – Aug 1, 2017 · Past
Ulrik B NielsenDirector · Jun 10, 2021 – Jun 6, 2023 · Past
William M McClementsHead of Corporate Operations · Jan 31, 2012 – Feb 29, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Merrimack Pharmaceuticals Inc.